Absorption patterns of meals containing complex carbohydrates in type 1 diabetes
- First Online:
- Cite this article as:
- Elleri, D., Allen, J.M., Harris, J. et al. Diabetologia (2013) 56: 1108. doi:10.1007/s00125-013-2852-x
- 1.4k Downloads
Successful postprandial glycaemia management requires understanding of absorption patterns after meals containing variable complex carbohydrates. We studied eight young participants with type 1 diabetes to investigate a large low-glycaemic-load (LG) meal and another eight participants to investigate a high-glycaemic-load (HG) meal matched for carbohydrates (121 g).
On Visit 1, participants consumed an evening meal. On follow-up Visit 2, a variable-target glucose clamp was performed to reproduce glucose and insulin levels from Visit 1. Adopting stable-label tracer dilution methodology, we measured endogenous glucose production on Visit 2 and subtracted it from total glucose appearance measured on Visit 1 to obtain meal-attributable glucose appearance.
After the LG meal, 25%, 50% and 75% of cumulative glucose appearance was at 88 ± 21, 175 ± 39 and 270 ± 54 min (mean ± SD), whereas glucose from the HG meal appeared significantly faster at 56 ± 12, 100 ± 25 and 153 ± 39 min (p < 0.001 to 0.003), and resulted in a 50% higher peak appearance (p < 0.001). Higher apparent bioavailability by 15% (p = 0.037) was observed after the LG meal. We documented a 20 min deceleration of dietary mixed carbohydrates compared with dietary glucose for the HG meal and a twofold deceleration for the LG meal.
Absorption patterns may be influenced by glycaemic load and/or meal composition, affecting optimum prandial insulin dosing in type 1 diabetes.
KeywordsGlucose absorption Glucose models Glycaemic load Stable-label tracer Tracer methodology Type 1 diabetes
Endogenous glucose production
- HG meal
- LG meal
In type 1 diabetes, modern approaches to management of postprandial glycaemia include carbohydrate counting , the use of bolus calculators  and administering rapid-acting insulin analogues  timed according to meal type and prevailing glycaemia [4, 5, 6, 7]. Gauging of prandial insulin aims to ameliorate elevated postprandial glucose levels, which correlate strongly with HbA1c , while reducing the risk of postprandial hypoglycaemia.
Informed by clinical observations, these management approaches lack mechanistic understanding of absorption patterns of commonly eaten meals containing complex carbohydrates. Using tracer dilution methodology , early investigations documented persistent abnormalities in glucose load absorption in type 1 diabetes [10, 11], and these were followed by studies documenting absent effects of hyperglycaemia  and insulin  on gastric emptying and glucose absorption. However, methodological challenges deterred investigation of meals containing non-glucose carbohydrates.
The common notion is that glucose is absorbed differently from other simple sugars and complex carbohydrates, and, although experimental proof in type 1 diabetes is missing, this has prevented assessment of common meals, with the exception of maize or wheat naturally or artificially enriched with 13C and studied in healthy participants [14, 15, 16] but not in type 1 diabetes.
In addition to obtaining mechanistic information to inform postprandial glycaemia management, the present study is motivated by research on overnight closed-loop insulin delivery in young people and our interest in absorption of large evening meals, which may complicate safe and efficacious closed-loop control . In this study, we combine an innovative experimental design with advanced, validated calculations to evaluate the systemic appearance of glucose after evening meals containing glucose and non-glucose carbohydrates. We contrast two representative high- and low-glycaemic-load meals matched for total carbohydrates but differing in fat and protein content to investigate the spectrum of absorption patterns.
Eight young participants with type 1 diabetes were enrolled to investigate a low-glycaemic-load (LG) meal. Another eight participants were enrolled to investigate a high-glycaemic-load (HG) meal. The study was approved by the local ethics committee, and participants provided written informed consent.
Participants were 16–24 years old. Inclusion criteria were type 1 diabetes for at least 6 months (WHO criteria or confirmed negative C-peptide), multiple daily injections or pump therapy, BMI <30 kg/m2 and HbA1c <12% (108 mmol/mol). Exclusion criteria were a total daily insulin dose >1.4 U/kg body weight, gastroparesis, pregnancy and intention to become pregnant.
Participants were admitted to the Wellcome Trust clinical research facility (Cambridge) on two occasions between 1 and 3 weeks (up to 5 weeks for two participants) apart. Those receiving multiple daily injections (LG meal, n = 5; HG meal, n = 7) stopped basal insulin at least 12 h before admission. Symptomatic hypoglycaemia within the preceding 48 h or moderate or intense exercise within the preceding 24 h led to the study visit being rescheduled.
Common procedures during Visit 1 and Visit 2
A primed constant continuous i.v. infusion of [6,6-2H2]glucose (6 mg/kg prime; 0.06 mg kg−1 min−1 continuous infusion; Cambridge Isotope Laboratories, Andover, MA, USA) was given over 150 min from 15:30 hours. From 18:00 hours, the infusion rate was altered in a manner that mimicked the expected post-meal suppression of EGP; [6,6-2H2]glucose was infused at a rate of 70%, 60%, 50%, 35%, 45%, 50%, 55%, 65% and 70% (100% represents the rate of 0.06 mg kg−1 min−1) at 0, 10, 20, 30, 220, 240, 280, 300 and 400 min after 18:00 hours.
From 18:00 hours, [U-13C; 1,2,3,4,5,6,6-2H7]glucose (Cambridge Isotope Laboratories) was infused in a manner that mimicked the expected glucose appearance from a standard meal; [U-13C; 1,2,3,4,5,6,6-2H7]glucose was infused at 20%, 40%, 55%, 70%, 90%, 100%, 90%, 70%, 50%, 40%, 30%, 20%, 10%, 5% and 0% of 0.1 mg kg−1 min−1 at 0, 10, 20, 30, 40, 50, 90, 120, 150, 180, 195, 225, 270, 330 and 405 min after 18:00 hours.
Visit 1: meal consumption
At 18:00 hours, eight participants consumed an LG meal (macaroni cheese; glycaemic load 54), while the other eight consumed an HG meal (vegetable shepherd’s pie; glycaemic load 105). Glycaemic index/load was determined by an experienced diabetes dietitian. Electronic supplementary material (ESM) Table 1 shows the detailed meal contents. The two meals were eaten over 20 min and matched for carbohydrates but not protein, fat or energy (carbohydrates/protein/fat 121:35:31 vs 121:20:9 g; 899 vs 615 kcal). The meals were enriched with 1.7 g [U-13C]glucose, dissolved in a small bottle with tepid water, bottle rinsed, content mixed in a serving bowl within the sauce before the bulk was added, and a bread slice used to clean the bowl at the end of the meal.
Visit 2: variable-target glucose clamp
From 18:00 hours, a variable i.v. 20% dextrose infusion enriched with [U-13C]glucose (13 mg/g) was infused over 8 h to replicate the individual post-meal plasma glucose excursions observed on Visit 1. An adaptive model predictive controller (gMPC, Version 1.0.2, University of Cambridge, Cambridge, UK) was used to adjust the dextrose infusion using information about the participant’s total daily insulin dose, the i.v. insulin delivery, and the target glucose profile.
From 10:00 hours during both visits, venous blood samples were taken every 10–15 min for the determination of plasma glucose. Samples were taken at 15:00, 15:15 and 15:30 hours to determine background glucose enrichments. From 17:00 hours, venous blood samples were taken every 10–30 min for the determination of plasma insulin, triacylglycerols, [U-13C]glucose, [6,6-2H2]glucose and [U-13C; 1,2,3,4,5,6,6-2H7]glucose. The samples were immediately centrifuged and separated. Plasma glucose was measured immediately, while other samples were stored at −80°C until assayed.
Plasma glucose was measured using a YSI2300 STAT Plus Analyser (YSI, Lynchford House, Farnborough, UK). Plasma insulin was measured using an immunochemiluminometric assay (Invitron, Monmouth, UK) with an intra-assay coefficient of variation of 4.7% and an interassay coefficient of variation of 7.2–8.1%. Plasma triacylglycerols were measured using an enzymatic assay (Siemens Healthcare, Erlangen, Germany) with an interassay coefficient of variation of 5.5% at 0.9 mmol/l and 3.4% at 2.4 mmol/l. Plasma samples were derivatised to form the methoxime-trimethylsilyl derivative for gas chromatography MS analysis (Agilent 5975C inert XL EI/CI MSD; Agilent Technologies, Wokingham, UK) to measure ions m/z 319.2 (M + 0), 321.2 (M + 2), 322.2 (M + 3), 323.2 (M + 4), 324.2 (M + 5) and 327.2 (M + 8) .
Tracer/tracee ratios were calculated using a variation of the method described previously [20, 21]. In brief, ions m/z M + 0, M + 2, M + 4 and M + 8 were used to calculate tracer/trace ratios of [6,6-2H2]glucose, [U-13C]glucose and [U-13C; 1,2,3,4,5,6,6-2H7]glucose corrected for recycled glucose using ions m/z M + 0, M + 3 and M + 5. The calculations accounted for spectra overlap . It was assumed that [U-13C; 1,2,3,4,5,6,6-2H7]glucose is recycled equally into glucose molecules with m/z of M + 4 and M + 5 and that [U-13C]glucose is recycled equally into glucose molecules with m/z of M + 2 and M + 3 [23, 24]. A system of algebraic equations was solved analytically, solution reduced and validated using Mathematica (Wolfram Research, Champaign, IL, USA). The endogenous glucose concentration was calculated using a model-independent method as described previously .
Modelling glucose kinetics
A stochastic modelling approach was used to estimate glucose turnover, adopting a hierarchical Bayes model implementing the Radziuk/Mari two-compartment model of glucose kinetics [26, 27]. The method used Bayesian inference with a regularising prior distribution that assumes smooth glucose fluxes  with individualised smoothness levels drawn from a population distribution . The method has been described previously  and validated against data collected on Visit 2 .
[U-13C; 1,2,3,4,5,6,6-2H7]Glucose and [U-13C]glucose were used to estimate the appearance of the meal tracer (Ra tracer) on Visit 1. This amounts to using the triple-tracer approach during Visit 1 and the single-tracer approach during Visit 2. The ESM Methods describe details of the computations.
LG vs HG meals were contrasted using an unpaired t test. Visit 1 vs Visit 2 was contrasted using a paired t test. For non-normally distributed data, Mann–Whitney and Wilcoxon tests were used. The incremental AUC above fasting was calculated using the trapezoidal rule. Results are presented as mean ± SD or median (interquartile range) as appropriate. Figures show data as mean ± SEM. Analyses were conducted with the use of SPSS, versions 15 and 19 (SPSS, Chicago, IL, USA). p values less than 0.05 were considered statistically significant.
The two groups of participants were comparable: LG meal: five male, age 20.8 ± 3.3 years, BMI 24.0 ± 1.5 kg/m2, HbA1c 8.7 ± 1.5%, diabetes duration 7.1 (2.9, 20.9) years, total daily insulin 0.8 ± 0.2 U kg−1 day−1; HG meal: four male, age 18.1 ± 4.0 years, BMI 22.8 ± 1.2 kg/m2, HbA1c 8.7 ± 2.0%, diabetes duration 7.4 (3.6, 11.2) years, total daily insulin 0.9 ± 0.1 U kg−1 day−1.
Plasma glucose, insulin and triacylglycerols
Plasma concentrations and glucose turnover during Visit 1 (meal consumption) and Visit 2 (variable-target glucose clamp) to investigate effects of an LG and HG meal
LG meal (n = 8)
HG meal (n = 8)
Plasma glucose, mmol/l
5.5 ± 0.6
5.7 ± 1.1
5.7 ± 0.5
5.7 ± 0.6
EGP, μmol kg−1 min−1
12 ± 1
12 ± 2
13 ± 1
12 ± 2
Glucose disposal, μmol kg−1 min−1
13 ± 1
13 ± 2
13 ± 1
12 ± 2
Plasma insulin, pmol/l
102 (49, 137)
94 (76, 191)
97 (58, 224)
97 (58, 210)
Plasma triacylglycerols, mmol/l
0.6 ± 0.3
0.6 ± 0.2
0.5 ± 0.3
0.5 ± 0.2
Meal consumption (Visit 1) and variable-target glucose clamp (Visit 2)
Plasma glucoseb, mol/l per 480 min
2.2 (0.9, 2.9)
2.0 (1.3, 2.6)
1.2 (1.1, 1.8)
1.2 (1.0, 1.8)
EGPb, mmol kg−1 min−1 per 480 min
3.8 (3.6, 4.8)
3.7 (3.4, 4.4)
Glucose disposalb, mmol kg−1 min−1 per 480 min
3.8 (2.0, 6.8)
6.0 (4.8, 11.8)
6.3 (4.6, 7.1)
6.6 (5.6, 7.1)
Plasma insulinb, nmol/l per 480 min
77 (65, 164)
96 (86, 133)
81 (71, 147)
98 (77, 143)
Plasma triacylglycerolsb, mmol/l per 480 min
82 (38, 102)
−55 (−105, −37)
14 (−30, 30)
−27 (−55, 21)
Eating an LG meal resulted in slower and sustained elevation of plasma glucose with an unpronounced peak of 11.7 ± 2.7 mmol/l within 153 ± 104 min compared with a distinct and earlier peak of 13.8 ± 3.5 mmol/l at 98 ± 29 min after an HG meal (see ESM Table 2 for further details). During the variable-target glucose clamp, fasting and postprandial glucose levels were well reproduced. The difference between paired plasma glucose levels between the two visits was 4.1% (2.0%, 8.0%).
Fasting plasma insulin was comparable between visits and meals. Despite identical basal (0.9 ± 0.3 vs 0.9 ± 0.2 U/h; p = 0.850; LG vs HG meal) and variable (14 ± 2 and 15 ± 4 U/h; p = 0.370) insulin delivery on the two visits, there was a trend for reduced plasma insulin during Visit 1 between 45 and 120 min during studies investigating both meals (Fig. 3). Plasma insulin peaked between 65 and 70 min, and the peak was higher on Visit 1 (p = 0.036 and p = 0.017). Overall, incremental plasma insulin did not differ between the two visits (p ≥ 0.208). A marked increase was observed in incremental plasma triacylglycerol after consumption of the LG meal compared with Visit 2 (p = 0.012). This pattern was not recorded after the HG meal, as documented by comparable incremental AUCs between visits with slow decline followed by recovery at the end of the study.
Tracer concentrations and glucose turnover
[U-13C]Glucose concentrations on the two visits differed considerably. This applied to both meals. On Visit 1, [U-13C]glucose concentration rose and declined more rapidly, whereas during Visit 2, lower [U-13C]glucose concentrations were observed and the dynamics were slower.
The pattern of dextrose infusion on Visit 2 differed between the two meals, whereas EGP was similar (Fig. 5). However, the trough of EGP occurred later with the HG meal (98 ± 42 vs 182 ± 62 min; p = 0.007).
Meal-attributable glucose absorption and meal tracer absorption
Apparent bioavailability and rate of glucose appearance after consumption of LG and HG meals enriched with [U-13C]glucose
LG meal (n = 8)
HG meal (n = 8)
Native glucose from dietary carbohydrates
Apparent bioavailability, %
102 ± 14
87 ± 12
Meal-attributable glucose appearance (Ra meal)
88 ± 21
56 ± 12
175 ± 39
100 ± 25
270 ± 54
153 ± 39
Peak absorption rate, μmol kg−1 min−1
40 ± 6
62 ± 8
Time to peak absorption rate, min
45 (30, 105)
40 (33, 58)
108 ± 25
114 ± 7
Tracer appearance (Ra tracer)
39 ± 13
46 ± 10
84 ± 30
82 ± 15
159 ± 42
135 ± 28
Peak absorption rate, μmol kg−1 min−1
1.9 ± 0.7
1.6 ± 0.3
Time to peak absorption rate, min
25 (20, 30)
30 (20, 38)
The absorption characteristics of the meal tracer were identical between the two meals (Table 2, ESM Fig. 1). In investigations of the LG meal, the meal tracer appeared about twice as rapidly as meal carbohydrates, as documented by time to peak, peak absorption rate and time to achieve 25%, 50% and 75% of cumulative glucose appearance. In investigations of the HG meal, the meal tracer appeared about 20 min faster. When normalised to carbohydrate amount, [U-13C]glucose achieved higher peak absorption than meal carbohydrates (p < 0.001).
To our knowledge, we are the first to evaluate absorption of commonly eaten meals containing complex carbohydrates in participants with type 1 diabetes. We have documented patterns influenced by glycaemic load. After an early peak at 45 min, a sustained slowly decreasing pattern lasting in excess of 8 h was observed after an LG meal, whereas an HG meal resulted in a 50% increase in peak appearance and absorption lasting less than 6 h. At least 15% more glucose appeared systemically after the LG meal despite the carbohydrate content of the two meals being identical.
Plasma glucose levels followed the absorption patterns. After a comparable increase of 2 mmol/l over the first 30 min after the meal, plasma glucose peaked at a higher level after the HG meal at 100 min and then decreased to basal levels within 5–6 h (Fig. 3). Plasma glucose continued to increase gradually after the LG meal throughout the experiment and failed to revert to basal. This suggests that an LG evening meal results in sustained overnight elevation of glucose and increased nocturnal exposure to hyperglycaemia. Adequate management of an LG meal may require prolonged insulin delivery such as that obtained through the use of the extended bolus feature of smart insulin pumps, and a larger prandial insulin amount may be needed to compensate for the additional glucose appearing after an LG meal in accordance with heuristic observations .
Glycaemic load and, definitely, meal composition are the most likely main determinants of differences in absorption patterns. Although plasma glucose excursions differs after the two different meals, hyperglycaemia does not affect gastric emptying or glucose absorption in type 1 diabetes . Similarly, plasma insulin does not appear to influence glucose absorption . The complexity of our studies prevented investigation of the two types of meal in the same population. However, participant characteristics, including sex, age, BMI, HbA1c and diabetes duration, were very similar and thus unlikely to have affected the outcomes.
From the rate of absorption of the meal tracer ([U-13C]glucose), we infer that mixed meals containing glucose are more rapidly absorbed, achieve a higher absorption peak, and have a distinct absorption pattern not representative of meals containing complex carbohydrates. Using a meal tracer as a marker of native glucose appearance, our study suggests a 20 min deceleration of dietary complex carbohydrates compared with dietary glucose for the HG meal and a twofold deceleration for the LG meal. This deceleration explains the difference in meal tracer concentration between the two visits (Fig. 4) and confirms that dietary glucose tracers are not suitable for measuring systemic appearance of complex carbohydrates in type 1 diabetes.
Most previous studies investigated meals or drinks containing glucose and, for methodological reasons, no other simple sugars or complex carbohydrates [10, 11, 12, 13, 25, 29, 31, 32, 33, 34, 35] have been looked at, with the notable exception of maize starch naturally enriched with 13C [14, 15] and intrinsically enriched starch from wheat subjected to a 13CO2-enriched atmosphere . The latter investigations did not aim to achieve a constant tracer/tracee ratio, traced only one source of complex carbohydrates (maize or wheat starch), and did not use advanced computational techniques, possibly affecting the accuracy of the measurements. Our study avoided these shortcomings. Another study assessed total glucose appearance after breakfast and dinner containing complex carbohydrates in type 1 diabetes complicated by pregnancy, but EGP and gut absorption could not be differentiated . In comparison with a study investigating a mixed meal containing 1.2 g glucose per kg body weight in healthy subjects , we observed a glucose absorption peak that was lower by 30% (HG meal) and 50% (LG meal) occurring 15–30 min later. Absorption was nearly complete within 5 h with the HG but not the LG meal.
Our approach adopts the conventional assumption of tracer indistinguishability and that the component of EGP, independently of dietary precursors, is identical on Visit 1 and Visit 2. We aimed to maintain the validity of the latter assumption by reproducing the levels of plasma glucose and plasma insulin on the two visits. By careful titration of i.v. insulin before the main study period, we achieved identical fasting conditions, including plasma glucose, plasma insulin and EGP. The variable-target glucose clamp gave identical plasma glucose levels. However, we observed higher plasma insulin on Visit 2, but this discrepancy was limited to a 75 min interval when EGP was maximally suppressed. We infer that the estimate of meal-attributable appearance is affected to a negligible extent given the large size of the meals relative to the background EGP, as exemplified by at least a tenfold difference between endogenous (∼3 μmol kg−1 min−1) and exogenous (30–60 μmol kg−1 min−1) glucose appearance during the affected period (Figs 5 and 6). Thus small inter-occasion differences in EGP have little effect on meal-attributable glucose appearance.
We dissected the measurement process into interlinked stages. Modelling of i.v. glucose tracer facilitated native glucose disposal estimation. Mass balance equations were then used to derive total glucose appearance. Physiological insights identified two components of EGP in relation to gluconeogenesis from a dietary precursor (Fig. 1). The dietary-precursor-independent EGP estimated on Visit 2 was subtracted from total glucose appearance estimated on Visit 1 to obtain meal-attributable glucose appearance. Differences in glucose disposal between the two visits were irrelevant, as glucose disposal on Visit 2 was not fed into the calculation process and was a byproduct of the study design. The contribution of the dietary-precursor component of EGP may explain, at least in part, the higher meal-attributable appearance by 20 g after the LG meal, which is richer in fat and proteins.
Methodological difficulties related to the non-steady-state of the glucoregulatory system in postprandial conditions and the intricacies of the computational problem (small measurement errors propagate into large estimation errors of glucose fluxes)  can be mitigated by minimising the change over time in the tracer/tracee ratio  in combination with the two-compartment model of glucose kinetics . An advanced stochastic computational approach was found to be effective for obtaining accurate measurements [29, 30] and was adopted in the present investigation.
Although we aimed to minimise changes over time of the tracer/tracee ratios to avoid the model-misspecification error, some variations occurred (ESM Fig. 2). However, our unique validation approach  demonstrated that the advanced computational technique is accurate given its ability to reconstruct accurately the dextrose infusion on Visit 2. It follows that the computational approach accurately reconstructs total glucose appearance and EGP. The computational approach assumes smooth glucose fluxes , with the extent of smoothing drawn from a population distribution. This allowed sharing of information among individuals  and avoided the aberrations and oscillations that can be present when data are processed individually.
The strength of our study is in the assessment of commonly eaten meals containing simple and complex carbohydrates, and the use of advanced and validated computational approaches. Limitations include investigating separate populations to assess the two meals, and the assumption that EGP was similar on the two study occasions. None of the shortcomings should affect the main study findings.
Our results can be used to explore, in silico , alternative insulin-dosing strategies, including closed-loop systems , before use in experiential and clinical settings. The results provide novel insights into glucose turnover suitable for incorporation into advanced mathematical models of glucose regulation .
We conclude that large evening meals containing complex carbohydrates provide different challenges to the management of type 1 diabetes depending on the meal composition. An HG meal results in a pronounced, but shorter, absorption pattern, whereas an LG meal results in sustained and prolonged absorption and higher overall glucose appearance.
A. Watts, Department of Paediatrics, University of Cambridge, provided laboratory support. D. Mundt and J. Weston, Cambridge University Hospitals NHS Foundation Trust, Cambridge, provided dietary support. The Diabetes Research Network Laboratory Wales (S. Luzio) measured plasma insulin. T. Hovorka, Institute of Metabolic Science, University of Cambridge, developed and validated tracer/tracee ratio calculations. We acknowledge support by the staff at the Addenbrooke’s Wellcome Trust Clinical Research Facility. We are grateful to study volunteers for their participation.
This work was supported by JDRF (no. 22-2006-1113, no. 22-2007-1801, no. 22-2009-801, no. 22-2009-802), Diabetes UK (BDA07/0003549), the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK085621), European Community Framework Programme 7 (FP7-SME-2010-1 grant number 262007), Medical Research Council Centre for Obesity and Related metabolic Diseases, National Institute for Health Research Cambridge Biomedical Research Centre.
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.
RH is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. RH, DE, DBD, CLA and MLE co-designed the studies. JMA and DE were responsible for patient screening and enrolment and informed consent. DE, JMA, KK, LL and JH provided patient care, contributed to acquisition of data, and contributed to biochemical analysis. NJ and AMU carried out GCMS analysis. DE, AH, MEW and MN carried out or supported the data analysis including the statistical analyses. RH and DE contributed to the interpretation of the results and drafted the manuscript. JMA, JH, KK, MN, LL, CLA, AH, MEW, NJ, AMU, MLE and DBD critically revised the manuscript. All authors have seen and approved the final version of the report.